The prolonged restricted conditions during pandemic lead to change in lifestyle, particularly eating habits and behaviors, and advocate for planned support efforts to provide nutrition during future pandemic crises.Moreover, false claims and exaggeration about health benefits of different nutrients should be avoided for better health outcomes.As there is no known effective cure or treatment for COVID, proper food intake and good nutritional status is an advantage for people at risk for severe COVID.Nutritional intervention through a healthy balanced diet comprised of whole grains, vegetables and fruits, nuts, legumes, dairy products, meat, and herbs is needed to boost immunity and reduce the incidence of infection and severity.Several vitamins and minerals are also important for immunomodulation and attenuate complications.Selection of right foods is perspective way to manage comorbidities, associated risk factors, and severe complications during COVID.The initial effort to repurpose the existing drugs approved for other ailments to kill the virus and treat the COVID makes sense.Worldwide, many laboratories are engaged in carrying out research on existing drugs to develop remedies for COVID.This will considerably shorten the total duration of drug discovery and development, which extends from laboratory investigations to initial toxicity testing to animal studies to safety studies in humans and, finally, largescale clinical trials.Here are some of the medicines currently being used in various parts of the world as potential remedies for COVID.This represents a significant improvement over the current treatment options available for COVID patients.The news of a preexisting, inexpensive medication reducing mortality in COVID patients came as a pleasant surprise after the continuous negative news of what seemed to be an unstoppable spread of novel coronavirus.The drug is available in large quantities in even developing countries and can be administered orally.This trials results were compelling, although they have surprised many people who are actively involved in finding a cure for COVID.Many experts in the field suggested that if these results hold up in larger, more powered clinical trials, this drug could be a gamechanger, especially for those COVID patients who are critically ill.After less than a month of treatment, there was a reduction in the mortality of severely ill patients who required ventilators.In patients who required supplemental oxygen but not ventilators, a reduction in mortality was observed.However, it appears that the drug is not beneficial in less severely ill patients and may exacerbate the disease.Some studies also suggested that patients with acute respiratory distress syndrome can also benefit from the use of dexamethasone.Two factors are crucial when managing COVID patients with dexamethasone selectiveness and timing.Initial investigations suggest that dexamethasone should not be used in patients who do not have severe symptoms of the disease and do not need additional oxygen, such as those requiring a ventilator.Even in patients in which dexamethasone is useful, it has certain drawbacks.It decreases an individuals ability to fight the virus because it dampens the overall immunity.Its lack of selectivity in inhibiting inflammatory pathways makes patients susceptible to several untoward effects, which include but are not limited to psychosis, emotional disturbances, and worsening diabetes mellitus.